Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00660426 · ClinicalTrials.gov registry record · Phase 1
Study Of Advanced Gastrointestinal Malignancies And Other Solid Tumors
A Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00660426 is a Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 30 participants.
The verdict
NCT00660426, a Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
Dose escalation of oxaliplatin, gemcitabine and capecitabine in the treatment of patients with advanced gastrointestinal malignancies and other solid tumors.
Interventions
- DRUG Capecitabine
- DRUG Oxaliplatin
- DRUG Gemcitabine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-03 |
| Est. Completion | 2008-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00660426
The ClinicalTrials.gov registry entry for NCT00660426 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Capecitabine is the first listed.
NCT00660426 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00660426 about?
NCT00660426 is a clinical study titled "Study Of Advanced Gastrointestinal Malignancies And Other Solid Tumors". Dose escalation of oxaliplatin, gemcitabine and capecitabine in the treatment of patients with advanced gastrointestinal malignancies and other solid tumors.
What is the current status of trial NCT00660426?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2005-03. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00660426?
The interventions under investigation include: Capecitabine (DRUG), Oxaliplatin (DRUG), Gemcitabine (DRUG).
Who is sponsoring clinical trial NCT00660426?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.